Register for streaming realtime charts, analysis tools, and prices.
The current KALV market cap is 591.12M. The company's latest EPS is USD -2.5474 and P/E is -4.67.
| Year End 30 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 12.69M | 0 | 0 | 0 | 0 |
| Operating Income | -40.53M | -57.92M | -96.61M | -110.87M | -140.45M |
| Net Income | -29.12M | -46.24M | -82.34M | -92.91M | -126.64M |
| Year End 30 April 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 92.53M | 272.01M | 203.88M | 183.2M | 235.4M |
| Total Liabilities | 8.78M | 14.82M | 18.79M | 22.18M | 28.82M |
| Total Equity | 83.75M | 257.19M | 185.09M | 161.03M | 206.58M |
| Market Cap | 591.12M |
| Price to Earnings Ratio | -4.67 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 18.61 |
| Price to Book Ratio | 2.86 |
| Dividend Yield | - |
| Shares Outstanding | 49.72M |
| Average Volume (1 week) | 457.02k |
| Average Volume (1 Month) | 637.18k |
| 52 Week Change | -3.33% |
| 52 Week High | 15.50 |
| 52 Week Low | 7.30 |
| Spread (Intraday) | 61.84 (86.02%) |
| Company Name | KalVista Pharmaceuticals Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.kalvista.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
